MARKET

PFE

PFE

Pfizer
NYSE
28.45
-0.36
-1.25%
After Hours: 28.45 0 0.00% 19:59 09/04 EDT
OPEN
28.58
PREV CLOSE
28.81
HIGH
28.69
LOW
28.38
VOLUME
23.79M
TURNOVER
--
52 WEEK HIGH
29.21
52 WEEK LOW
22.03
MARKET CAP
162.16B
P/E (TTM)
37.67
1D
5D
1M
3M
1Y
5Y
1D
Pfizer Ramps Up Obesity And Eczema Bets, Investors Watch
TipRanks · 1d ago
Inovio Pharmaceuticals Inc. Stock Rises 5.1%, Outperforms Peers
Dow Jones · 2d ago
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool · 2d ago
Pfizer’s Next Move in Obesity Drugs: What the New VESPER-JM Trial Means for PFE Investors
TipRanks · 2d ago
Pfizer Steps Up in Obesity Race With New Phase 3 Berobenatide Trial in Japan
TipRanks · 2d ago
Pfizer’s Tilrekimig Eczema Trial: A Fresh Phase 3 Catalyst for PFE Investors
TipRanks · 2d ago
Pfizer’s Migraine Tablet Study Wraps Up, Supporting Pipeline Flexibility for PFE Investors
TipRanks · 2d ago
AMGN's MariTide: Can Convenience Drive its Obesity Market Share?
NASDAQ · 2d ago
More
About PFE
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, and others. Its PF-08653944 is an ultra-long-acting fully biased GLP-1 receptor agonist.

Webull offers Pfizer Inc stock information, including NYSE: PFE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PFE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PFE stock methods without spending real money on the virtual paper trading platform.